What is the longest-acting local anesthetic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Longest-Acting Local Anesthetics

Bupivacaine, levobupivacaine, and ropivacaine are the longest-acting local anesthetics available, with bupivacaine and levobupivacaine providing anesthesia lasting up to 7 hours in dental applications and significantly longer than intermediate-acting agents like lidocaine and mepivacaine across all regional anesthesia techniques. 1, 2

Duration Comparison

The long-acting local anesthetics are classified as a distinct pharmacologic category separate from short-acting (procaine, chloroprocaine) and intermediate-acting agents (lidocaine, mepivacaine, prilocaine). 3

Bupivacaine provides the longest duration among commonly used agents:

  • Duration is 2-3 times longer than lidocaine and mepivacaine in dental procedures 2
  • Can provide anesthesia lasting up to 7 hours in many patients 2
  • Followed by a period of analgesia after sensation returns, reducing need for strong analgesics 2
  • Peak plasma levels occur at 30-45 minutes, with decline to insignificant levels over 3-6 hours 2

Levobupivacaine offers equivalent duration to bupivacaine:

  • Clinically equivalent in anesthetic potency and duration to bupivacaine 4
  • Produces similar onset, duration, and density of block as bupivacaine at comparable doses 4
  • Provides improved cardiovascular safety profile compared to racemic bupivacaine 4

Ropivacaine provides comparable long-acting anesthesia:

  • Classified alongside bupivacaine and levobupivacaine as a long-acting agent in current guidelines 1, 5
  • Allows higher maximum dosing (3 mg/kg vs 2.5 mg/kg for bupivacaine) 1, 5
  • Offers potential advantages in cardiovascular safety over bupivacaine 6

Clinical Application Across Techniques

All three long-acting agents are recommended equivalently across regional anesthesia techniques by the European Society for Paediatric Anaesthesiology 2024 guidelines:

  • Wound infiltration and peripheral nerve blocks 1
  • Epidural blocks (thoracic and lumbar) 1
  • Caudal blocks 1
  • Paravertebral blocks 1
  • Fascia iliaca and femoral nerve blocks 1
  • TAP and rectus sheath blocks 1

Duration Enhancement Strategies

Adding epinephrine 1:200,000 prolongs duration:

  • Reduces rate of absorption and peak plasma concentration 2
  • Permits use of moderately larger total doses 2
  • Sometimes prolongs duration of action 2

Adding preservative-free clonidine 1-2 mcg/kg extends block duration:

  • Recommended across multiple block types in current guidelines 1, 5
  • Provides reliable and predictable analgesia lasting 4-8 hours or longer 7
  • Carries hemodynamic risks including hypotension and bradycardia requiring monitoring 8

Critical Safety Distinction

While all three agents provide equivalent duration, bupivacaine carries the highest cardiotoxicity risk, particularly after unintended intravascular injection, with potential for fatal ventricular arrhythmias and cardiac arrest. 2, 4 Levobupivacaine demonstrates significantly less CNS and cardiotoxicity than bupivacaine in preclinical and clinical studies, with less effect on myocardial contractility and QTc prolongation. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacology of local anesthetic agents.

Journal of dental research, 1981

Research

Levobupivacaine: a new safer long acting local anaesthetic agent.

Expert opinion on investigational drugs, 1999

Guideline

Regional Anesthesia with Ropivacaine and Bupivacaine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Long-acting local anesthetics in dentistry.

Anesthesia progress, 1992

Guideline

Dosis de Bupivacaína

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adjuvants in Spinal Anesthesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the differences in pharmacology, including mechanism of action, pharmacological effects, indications, contraindications, side effects, and dosage, among local anesthetics such as lidocaine, bupivacaine (Marcaine), EMLA (Eutectic Mixture of Local Anesthetics), and other agents?
Which of the following local anesthetics, bupivacaine (Bupivacaine), ropivacaine (Ropivacaine), mepivacaine (Mepivacaine), or lidocaine (Lidocaine), carries the greatest risk of local anesthetic toxicity?
Is bupivacaine (local anesthetic) safe to use during breastfeeding?
What is the onset and duration of action of bupivacaine in epidural anesthesia?
What are the alternatives to lidocaine (local anesthetic) for a patient requiring local anesthesia?
What is the best treatment approach for a 9-year-old child with Autism Spectrum Disorder (ASD), anxiety disorder, and Attention Deficit Hyperactivity Disorder (ADHD), weighing 50 pounds?
What is trigger finger, also known as stenosing tenosynovitis, in adults, particularly those with diabetes or rheumatoid arthritis?
What is the management approach for a patient with suspected drug-induced pancreatitis, particularly those with a history of pancreatic disease or taking medications such as azathioprine, valproic acid, or didanosine?
How should hypertension be managed in a patient with right bundle branch block (RBBB)?
What is the maximum Total Parenteral Nutrition (TPN) osmolarity for peripheral access?
What is the most appropriate next step for an 18-month-old child with a family history of celiac disease, normal growth and weight, and no symptoms, whose older sibling has celiac disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.